Search Results

There are 25258 results for: content related to: Botulinum Toxin and Pregnancy

  1. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology

    Muscle & Nerve

    Volume 20, Issue S6, 1997, Pages: 146–168, Mitchell F. Brin

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  3. Botulinum toxin injections for adults with overactive bladder syndrome

    Intervention Review

    The Cochrane Library

    James B Duthie, Michael Vincent, G Peter Herbison, David Iain Wilson and Don Wilson

    Published Online : 7 DEC 2011, DOI: 10.1002/14651858.CD005493.pub3

  4. Pharmacotherapy with Botulinum Toxin: Harnessing Nature's Most Potent Neurotoxin

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 20, Issue 9, September 2000, Pages: 1079–1091, Dr. Mark S. Bell, Mr. Lee C. Vermeulen and Dr. Keith B. Sperling

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.20.13.1079.35040

  5. S1 guideline aesthetic botulinum toxin therapy

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 11, Issue 10, October 2013, Pages: e1–e13, Matthias Imhof, Maurizio Podda and Boris Sommer

    Version of Record online : 25 SEP 2013, DOI: 10.1111/ddg.12195

  6. You have free access to this content
    Botulinum toxin type A versus botulinum toxin type B for cervical dystonia

    Intervention Review

    The Cochrane Library

    Gonçalo S Duarte, Mafalda Castelão, Filipe B Rodrigues, Raquel E Marques, Joaquim Ferreira, Cristina Sampaio, Austen P Moore and João Costa

    Published Online : 26 OCT 2016, DOI: 10.1002/14651858.CD004314.pub3

  7. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  8. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  9. You have free access to this content
    Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 6, June 2000, Pages: 829–834, Gui, De Gaetano, P. Luigi Spada, Viggiano, Cassetta and Albanese

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00765.x

  10. You have free access to this content
    Botulinum Toxin Type A as a Migraine Preventive Treatment

    Headache: The Journal of Head and Face Pain

    Volume 40, Issue 6, June 2000, Pages: 445–450, Stephen Silberstein, Ninan Mathew, Joel Saper, Stephen Jenkins and for the BOTOX Migraine Clinical Research Group

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1526-4610.2000.00066.x

  11. Efficacy of Botulinum Toxin Type A for the Prophylaxis of Episodic Migraine Headaches: A Meta-analysis of Randomized, Double-Blind, Placebo-Controlled Trials

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 7, July 2009, Pages: 784–791, Mr. Adam J. Shuhendler, Ms. Soyoung Lee, Ms. Ms. Michelle Siu, Ms. Ms. Stephanie Ondovcik, Ms. Ms. Kyla Lam, Ms. Ms. Awatif Alabdullatif, Ms. Ms. Xiaochu Zhang, Dr. Márcio Machado and Dr. Thomas R. Einarson

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.7.784

  12. Cholinergic Receptors and Botulinum Toxin

    Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management

    Brian E. Cairns, Pages: 297–324, 2009

    Published Online : 5 AUG 2009, DOI: 10.1002/9780470522226.ch12

  13. You have free access to this content
    Botulinum toxin for masseter hypertrophy

    Intervention Review

    The Cochrane Library

    Zbys Fedorowicz, Esther J van Zuuren and Jan Schoones

    Published Online : 9 SEP 2013, DOI: 10.1002/14651858.CD007510.pub3

  14. Growth effects of botulinum toxin type A injected into masseter muscle on a developing rat mandible

    Oral Diseases

    Volume 14, Issue 7, October 2008, Pages: 626–632, J-Y Kim, S-T Kim, S-W Cho, H-S Jung, K-T Park and H-K Son

    Version of Record online : 6 MAR 2008, DOI: 10.1111/j.1601-0825.2007.01435.x

  15. Botulinum toxin: Historical perspective and potential new indications

    Muscle & Nerve

    Volume 20, Issue S6, 1997, Pages: 129–145, Joseph Jankovic and Mitchell F. Brin

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-4598(1997)6+<129::AID-MUS9>3.0.CO;2-B

  16. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  17. Poster session 6: Clinical electrophysiology, dystonia

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S264–S310,

    Version of Record online : 21 OCT 2002, DOI: 10.1002/mds.10354

  18. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions

    European Journal of Neurology

    Volume 8, Issue s5, November 2001, Pages: 21–29, K. R. Aoki and B. Guyer

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1468-1331.2001.00035.x

  19. Botulinum toxin type A in the healing of chronic lesion following bilateral spasticity of gluteus muscle

    International Wound Journal

    Volume 11, Issue 4, August 2014, Pages: 412–415, Emanuele Cigna, Michele Maruccia, Benedetta Fanelli and Nicolò Scuderi

    Version of Record online : 19 OCT 2012, DOI: 10.1111/j.1742-481X.2012.01111.x

  20. Response to botulinum toxin F in seronegative botulinum toxin A—resistant patients

    Movement Disorders

    Volume 11, Issue 2, March 1996, Pages: 181–184, Dr. Paul E. Greene and Stanley Fahn

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870110211